1887

Abstract

Persistent infection by hepatitis B virus (HBV) correlates with the prevalence of hepatocellular carcinoma. It has recently been demonstrated that the complete viral genome very efficiently transforms the immortalized murine hepatocyte line FMH202 Here it is shown that the viral transactivating protein X (HBx) is sufficient to transform FMH202 cells, albeit with lower efficiency. Clonal cell lines expressing HBx mRNA in moderate or high amounts grew in soft agar and formed tumours in nude mice. Growth efficiency in soft agar of HBx transformed cell lines was much lower than that of cell lines transformed with the complete genome, and latency of tumour induction in nude mice was significantly longer after inoculation of HBx than of HBV transformed FMH202 cell lines. A marker of complete transformation, p53, was found to be phosphorylated more strongly in HBx transfected cell lines than in controls, and a cellular kinase was found to be associated with p53 complexes from HBx transformed cell lines. p53 was of wild-type conformation and was located in the nucleus of transformed cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-4-767
1998-04-01
2024-12-06
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/4/9568972.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-4-767&mimeType=html&fmt=ahah

References

  1. Appel K., Wagner P., Boldyreff B., Issinger O., Montenarh M. 1995; Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta sub-unit of protein kinase CK2. Oncogene 11:1971–1978
    [Google Scholar]
  2. Balsano C., Billet O., Bennoun M., Cavard C., Zider A., Grimber G., Natoli G., Briand P., Levrero M. 1994; Hepatitis B virus X gene product acts as a transactivator in vivo . Journal of Hepatology 21:103–109
    [Google Scholar]
  3. Beasley R. P., Hwang L. Y. 1984; Hepatocellular carcinoma and hepatitis B virus. Seminars in Liver Disease 4:113–121
    [Google Scholar]
  4. Chirillo P., Pagano S., Natoli G., Puri P. L., Burgio V. L., Balsano C., Levrero M. 1997; The hepatitis B virus X gene induces p53- mediated programmed cell death. Proceedings of the National Academy of Sciences, USA 94:8162–8167
    [Google Scholar]
  5. Doria M., Klein N., Lucito R., Schneider R. J. 1995; The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO Journal 14:4747–4757
    [Google Scholar]
  6. Feitelson M. A., Zhu M., Duan L. X., London W. T. 1993; Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109–1117
    [Google Scholar]
  7. Gorman C. 1985; High efficiency gene transfer into mammalian cells. In DNA Cloning - A Practical Approach pp. 143–190 Glover D. Edited by Washington & Oxford: IRL Press;
    [Google Scholar]
  8. Henkler F., Koshy R. 1996; Multiple functions of the hepatitis B virus X protein. Viral Hepatitis Reviews 2:143–159
    [Google Scholar]
  9. Hildt E., Hofschneider P. H., Urban S. 1996; The role of hepatitis B virus (HBV) in the development of hepatocellular carcinoma. Seminars in Virology 7:333–347
    [Google Scholar]
  10. Hinds P. W., Weinberg R. A. 1994; Tumor suppressor genes. Current Opinion in Genetics and Development 4:135–141
    [Google Scholar]
  11. Hoffmann B., Piasecki A., Paul D. 1989; Proliferation of fetal rat hepatocytes in response to growth factors and hormones in primary culture. Journal of Cell Physiology 139:654–662
    [Google Scholar]
  12. Höhne M., Piasecki A., Ummelmann E., Paul D. 1987; Transformation of differentiated neonatal rat hepatocytes in primary culture by polyoma virus early region sequences. Oncogene 1:337–345
    [Google Scholar]
  13. Höhne M., Schaefer S., Seifer M., Feitelson M. A., Paul D., Gerlich W. H. 1990; Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO Journal 9:1137–1145
    [Google Scholar]
  14. Höhne M. W., Zieroth S., Veser U., Kahl G. F., Schwarz L. R. 1993; Carcinogen-induced diploid hepatocytes: sensitive target cells for transformation by mutated c-Ha-ras oncogene. Molecular Carcinogenesis 7:180–189
    [Google Scholar]
  15. Kim C. M., Koike K., Saito I., Miyamura T., Jay G. 1991; HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317–320
    [Google Scholar]
  16. Klein R., Schröder C. H., Zentgraf H. 1991; Expression of the X protein of hepatitis B virus in insect cells using recombinant baculoviruses. Virus Genes 5:157–174
    [Google Scholar]
  17. Kunkel T. A. 1985; Rapid and efficient site-specific mutagenesis without phenotypic selection. Proceedings of the National Academy of Sciences, USA 82:488–492
    [Google Scholar]
  18. Lane D. P., Stephen C. W., Midgley C. A., Sparks A., Hupp T. R., Daniels D. A., Greaves R., Reid A., Vojtesek B., Picksley S. M. 1996; Epitope analysis of the murine p53 tumour suppressor protein. Oncogene 12:2461–2466
    [Google Scholar]
  19. Lee T. H., Finegold M. J., Shen R. F., DeMayo J. L., Woo S. L., Butel J. S. 1990; Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. Journal of Virology 64:5939–5947
    [Google Scholar]
  20. Luber B., Arnold N., Stürzl M., Höhne M., Schirmacher P., Lauer U., Wienberg J., Hofschneider P. H., Kekulé A. S. 1996; Hepatoma-derived integrated HBV-DNA causes multi-stage transformation in vitro . Oncogene 12:1597–1608
    [Google Scholar]
  21. Mosner J., Mummenbrauer T., Bauer C., Sczakiel G., Grosse F., Deppert W. 1995; Negative feedback regulation of wild-type p53 biosynthesis. EMBO Journal 14:4442–4449
    [Google Scholar]
  22. Müller E., Boldyreff B., Scheidtmann K. H. 1993; Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells. Oncogene 8:2193–2205
    [Google Scholar]
  23. Myers R. M., Larin Z., Maniatis T. 1985; Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA duplexes. Science 230:1242–1246
    [Google Scholar]
  24. Oguey D., Dumenco L. L., Pierce R. H., Fausto N. 1996; Analysis of the tumorigenicity of the X gene of HBV in a non-transformed hepatocyte cell line and the effects of cotransfection with murine p53 mutant equivalent to human codon 249. Hepatology 24:1024–1033
    [Google Scholar]
  25. Paul D., Höhne M., Pinkert C., Piasecki A., Ummelmann E., Brinster R. L. 1988; Immortalized differentiated hepatocyte lines derived from transgenic mice harboring SV40 T-antigen genes. Experimental Cell Research 175:354–362
    [Google Scholar]
  26. Perfumo S., Amicone L., Colloca S., Giorgio M., Pozzi L., Tripodi M. 1992; Recognition efficiency of the hepatitis B virus poly-adenylation signals is tissue specific in transgenic mice. Journal of Virology 66:6819–6823
    [Google Scholar]
  27. Robinson W. S. 1994; Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annual Review of Medicine 45:297–323
    [Google Scholar]
  28. Rogler C. E., Chisari F. V. 1992; Cellular and molecular mechanisms of hepatocarcinogenesis. Seminars in Liver Disease 12:265–278
    [Google Scholar]
  29. Schaefer S., Gerlich W. H. 1995; In vitro transformation by hepatitis B virus DNA. Intervirology 38:143–154
    [Google Scholar]
  30. Scheidtmann K. H. 1989; SV40 large T antigen induces a protein kinase responsible for phosphorylation of the cellular protein p53. Current Topics in Microbiology and Immunology 144:85–88
    [Google Scholar]
  31. Schek N., Bartenschlager R., Kuhn C., Schaller H. 1991; Phosphorylation of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene 6:1735–1744
    [Google Scholar]
  32. Schmieg F. I., Simmons D. T. 1984; Intracellular location and kinetics of complex formation between simian virus 40 T antigen and cellular protein p53. Journal of Virology 52:350–355
    [Google Scholar]
  33. Seifer M., Gerlich W. H. 1992; Increased growth of permanent mouse fibroblasts in soft agar after transfection with hepatitis B virus DNA. Archives of Virology 126:119–128
    [Google Scholar]
  34. Seifer M., Heermann K. H., Gerlich W. H. 1990a; Expression pattern of the hepatitis B virus genome in transfected mouse fibroblasts. Virology 179:287–299
    [Google Scholar]
  35. Seifer M., Heermann K. H., Gerlich W. H. 1990b; Replication of hepatitis B virus in transfected nonhepatic cells. Virology 179:300–311
    [Google Scholar]
  36. Seifer M., Höhne M., Schaefer S., Gerlich W. H. 1991; In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. Journal of Hepatology 13:S61–S65
    [Google Scholar]
  37. Shin S. I., Freedman V. H., Risser R., Pollack R. 1975; Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro . Proceedings of the National Academy of Sciences, USA 72:4435–4439
    [Google Scholar]
  38. Shirakata Y., Kawada M., Fujiki Y., Sano H., Oda M., Yaginuma K., Kobayashi M., Koike K. 1989; The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Japanese Journal of Cancer Research 80:617–621
    [Google Scholar]
  39. Su F., Schneider R. J. 1997; Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proceedings of the National Academy of Sciences, USA 94:8744–8749
    [Google Scholar]
  40. Takada S., Kaneniwa N., Tsuchida N., Koike K. 1997; Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene 15:1895–1901
    [Google Scholar]
  41. Treinin M., Laub O. 1987; Identification of a promoter element located upstream from the hepatitis B virus X gene. Molecular and Cellular Biology 7:545–548
    [Google Scholar]
  42. Truant R., Antunovic J., Greenblatt J., Prives C., Cromlish J. A. 1995; Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. Journal of Virology 69:1851–1859
    [Google Scholar]
  43. Ueda H., Ullrich S. J., Gangemi J. D., Kappel C. A., Ngo L., Feitelson M. A., Jay G. 1995; Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genetics 9:41–47
    [Google Scholar]
  44. Wang X. W., Forrester K., Yeh H., Feitelson M. A., Gu J. R., Harris C. C. 1994; Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proceedings of the National Academy of Sciences, USA 91:2230–2234
    [Google Scholar]
  45. Wang X. W., Gibson M. K., Vermeulen W., Yeh H., Forrester K., Sturzbecher H. W., Hoeijmakers J. H., Harris C. C. 1995; Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Research 55:6012–6016
    [Google Scholar]
  46. Zahm P., Hofschneider P. H., Koshy R. 1988; The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene 3:169–177
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-79-4-767
Loading
/content/journal/jgv/10.1099/0022-1317-79-4-767
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error